Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
Clinical trial NCT02562066 · COMPLETED
Trial details
- NCT number
- NCT02562066
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.